The field of the invention relates to balloon dilation devices, devices for illuminating nasal and sinus cavities, and methods for the treatment of sinusitis.
Sinusitis is a condition affecting over 35 million Americans, and similarly large populations in the rest of the developed world. Sinusitis occurs when one or more of the four paired sinus cavities (i.e., maxillary, ethmoid, frontal, sphenoid) becomes obstructed, or otherwise has compromised drainage. Normally the sinus cavities, each of which are lined by mucosa, produce mucous which is then moved by beating cilia from the sinus cavity out to the nasal cavity and down the throat. The combined sinuses produce approximately one liter of mucous daily, so the effective transport of this mucous is important to sinus health.
Each sinus cavity has a drainage pathway or outflow tract opening into the nasal passage. This drainage passageway can include an ostium, as well as a “transition space” in the region of the ostia, such as the “frontal recess,” in the case of the frontal sinus, or an “ethmoidal infundibulum,” in the case of the maxillary sinus. When the mucosa of one or more of the ostia or regions near the ostia become inflamed, the egress of mucous is interrupted, setting the stage for an infection and/or inflammation of the sinus cavity, i.e., sinusitis. Though many instances of sinusitis may be treatable with appropriate medicates, in some cases sinusitis persists for months or more, a condition called chronic sinusitis, and may not respond to medical therapy. Some patients are also prone to multiple episodes of sinusitis in a given period of time, a condition called recurrent sinusitis.
Balloon dilation has been applied to treat constricted sinus passageways for the treatment of sinusitis. These balloon dilation devices typically involve the use of an inflatable balloon located at the distal end of a catheter such as a balloon catheter. Generally, the inflatable balloon is inserted into the constricted sinus passageway in a deflated state. The balloon is then expanded to open or reduce the degree of constriction in the sinus passageway being treated to facilitate better sinus drainage and ventilation.
Exemplary devices and methods particularly suited for the dilation of anatomic structures associated with the maxillary and anterior ethmoid sinuses are disclosed, for example, in U.S. Pat. No. 7,520,876 and U.S. Patent Application Publication No. 2008-0172033. Other systems have been described for the treatment of various other sinuses including the frontal sinus. For example, U.S. Patent Application Publication No. 2008-0097295 discloses a frontal sinus guide catheter (
In a first embodiment of the invention, a balloon dilation catheter includes a substantially rigid inner guide member and a movable shaft coupled to a balloon that is slidably mounted on the substantially rigid inner guide member. To treat a drainage pathway of a sinus cavity (e.g., frontal sinus cavity) of a subject using the balloon dilation catheter, the substantially rigid inner guide member is advanced into a drainage pathway of the subject via a nasal passageway. The shaft and balloon are then advanced in a distal direction over the substantially rigid inner guide member to place the balloon in the drainage pathway. This enables the balloon to track over the inner guide member. The balloon is inflated to expand or otherwise remodel the drainage pathway. Where the sinus cavity is the frontal sinus cavity the drainage pathway is the frontal recess.
In another aspect of the invention, a device for dilating the outflow tract of a sinus cavity includes a substantially rigid inner guide member having a proximal end and a distal end and a shaft coupled to a balloon, the shaft having a first lumen along at least a portion thereof containing the substantially rigid inner guide member, the shaft having a second lumen operatively coupled to the interior of the balloon. A handle is disposed along a proximal portion of the substantially rigid inner guide member, the handle including a moveable knob operatively coupled to the shaft, wherein distal advancement of the knob advances the shaft and balloon over the substantially rigid inner guide in a distal direction.
In further aspects of the invention, taught herein are methods of treating a sinus cavity of a subject. In some embodiments the method includes advancing a distal portion of a light source through a drainage pathway of a frontal sinus cavity of a subject and into the frontal sinus cavity; visually observing a transdermal light emitted from the distal portion of the light source in the frontal sinus cavity; advancing a distal portion of a substantially rigid inner guide member of a balloon dilation catheter into the drainage pathway of the frontal sinus cavity, the balloon dilation catheter including a movable shaft slidably mounted on the substantially rigid inner guide member, the movable shaft including a balloon; advancing the movable shaft and balloon distally over the substantially rigid inner guide member to place a portion of the balloon in the drainage pathway; and inflating the balloon.
Alternatively, the inner guide member 14 may have some degree of malleability such that the user may bend or impart some desired shape or configuration to the distal end of the inner guide member 14. As explained herein in more detail, the inner guide member 14 may include an optional lumen 18 (best illustrated in
Still referring to
Still referring to
As seen in
Referring to
The inner guide member 14 may have a length of about 7 inches to about 11 inches from the distal end 20 to the proximal end 21 when loaded into the handle 12, although other dimensions may be used. The inner guide member 14 may be formed from stainless steel hypotube having an inner diameter in the range of about 0.019 inch to about 0.050 inch, and more preferably between about 0.036 inch and 0.040 inch, with a wall thickness within the range of about 0.005 inch to about 0.020 inch, and more preferably between about 0.008 inch to about 0.012 inch. The curved distal portion 16 of the inner guide member 14 may be formed right to the distal end 20 and may have a radius of curvature of about 0.25 inch to about 1.5 inch, and more preferably about 0.75 to about 1.25 inch.
The length of the inner guide member 14 that projects distally from the distal-most portion of the balloon 36 is about 0.5 inch to about 2.0 inch, and more preferably, about 0.8 inch to about 1.2 inch when the balloon 36 is in the fully retracted state (e.g., illustrated in
The balloon 36 is mounted on the shaft 30 so as to form a fluidic seal between the two components. The balloon 36 may be bonded to the shaft using a weld, adhesive, or the like. Alternately, the balloon 36 may be secured to the shaft using a mechanical connection. Generally, any technique known to those skilled in the art may be used to secure to the balloon 36 to the shaft 30. Given that the balloon 36 is secured directly to the shaft 30, both structures are slidably mounted over the inner guide member 14. The balloon 36 generally takes on a cylindrical-shape when inflated. While not limited to specific dimensions, the inflated balloon 36 has a diameter within the range of about 3 mm to about 9 mm, and more preferably a diameter within the range of about 5 to about 7 mm when inflated. The length of the balloon 36 may generally fall within the range of about 10 mm to 25 mm although other lengths may be used. Both the shaft 30 and the balloon 36 are preferably formed of high strength but flexible polymeric materials such as polyamides (e.g., Nylon), PEBAX or the like. The balloon 36 may be “blow molded” to a relatively thin wall thickness, and capable of holding relatively high pressures from about 6 atmospheres to about 20 atmospheres of inflation pressure. The balloon 36 is inflated using a fluid which is typically a liquid such as water or saline.
Referring now to
As best seen in
The helical portion 52 of the shaft 30 may be formed by “skiving” away a portion of the shaft 30.
For example, U.S. Pat. Nos. 5,391,199 and 5,443,489, which are incorporated by reference, describe a system wherein coordinates of an intrabody probe are determined using one or more field sensors such as, Hall effect devices, coils, or antennas that are carried on the probe. U.S. Patent Application Publication No. 2002-0065455, which is also incorporated by reference, describes a system that is capable of generating a six-dimensional position and orientation representation of the tip of a catheter using a combination of sensor and radiation coils. U.S. Patent Application Publication No. 2008-0269596, which is also incorporated by reference, describes yet another monitoring system that has particular applications in orthopedic procedures. Commercial systems such as the LANDMARX Element (Medtronic Xomed Products, Inc., Jacksonville, Fla.) are available for use in conjunction with ENT procedures.
In the embodiment of
Other commercial systems may also be used in connection with the balloon dilation catheter 10 illustrated in
Referring now to
Now referring to
After the frontal recess 102 has been widened or otherwise remodeled, the balloon 36 is deflated and removed as illustrated in
In certain patients, treatment of one or both frontal sinuses 104 as described above may be adequate. In other patients, additional sinuses may need to be treated, particularly the maxillary and/or anterior ethmoid sinuses. In such patients, a combination procedure may be well suited. The maxillary and/or anterior ethmoid sinuses can be treated with a system such as described in U.S. Pat. No. 7,520,876 and U.S. Patent Application Publication No. 2008-0172033, commercially available as the FinESS system by Entellus Medical, Inc. of Maple Grove, Minn. Alternatively, other sinuses could be treated more conventionally using surgical techniques such as, for instance, functional endoscopic sinus surgery (FESS).
Also, the sphenoid and/or maxillary sinus outflow tracts could be dilated with the embodiment of the balloon catheter 10 described above. It is also contemplated that the balloon catheter 10, particularly the embodiment of
In some embodiments, the invention includes the use of a light source to help a practitioner identify portions of, or confirm a location within, a sinus cavity or sinus cavity drainage pathway. For example, in some embodiments, a distal portion of a lighted instrument (e.g., a lighted guidewire, a lighted endoscope, or a lighted probe) is inserted into a subject via a transnasal route and directed into a space or body lumen that a practitioner suspects is a part of the frontal drainage pathway that leads to a frontal sinus cavity. The practitioner directs the lighted distal end of the instrument into the suspected pathway and gently advances the instrument further into the body lumen. If the lumen leads to a frontal sinus cavity, the light from the distal tip will travel through the bone and tissue walls of the cavity and provide a transdermal or transcutaneous illumination pattern visible to the practitioner. In this way, the practitioner can confirm that the suspected body lumen is a part of the frontal drainage pathway and does in fact lead to a frontal sinus cavity. Manipulation of the instrument (e.g., rotation) will move the illumination pattern, further confirming the positioning the instrument in the frontal recess. Once confirmed as part of the drainage pathway, the practitioner can use the other embodiments of this invention discussed above to dilate all or parts of the pathway. Typically, the lighted instrument would be removed from the frontal recess prior to the placement of any embodiment of the invention used to dilate all or parts of the pathway.
In another example, in some embodiments of the invention, a distal portion of a lighted instrument is used to confirm that a given location is within the maxillary sinus cavity. The practitioner directs the lighted distal end of the instrument to the location and looks for a visible transdermal or transcutaneous illumination pattern (e.g., an illumination pattern on the roof of the mouth or through the skin near the cheekbone). Once the pattern is observed, the practitioner then knows the given location is within the maxillary sinus cavity. If the pattern is not observed, the practitioner then knows the given location is unlikely to be within the maxillary sinus cavity.
In some embodiments, the lighted instrument is a lighted probe, such as device 1300 as illustrated in
Lighted probe device 1300 includes a handle portion 1302 forming a proximal portion of device 1300. Handle portion 1302 is configured to be gripped or otherwise manipulated by the operator. Attached to handle portion 1302 is an elongate-shaped probe member 1304 formed from a suitably rigid material such as a stainless steel hypotube. Probe member 1304 projects or otherwise extends distally from handle 1302. Probe member 1304 is pre-shaped to have a curved distal portion 1306. The nature and degree of curvature of probe member 1304 can be configured to match with the frontal sinus outflow tract or frontal recess. In some embodiments, probe member 1304 has some degree of malleability such that a user may bend or impart some desired shape or configuration to the distal end of probe member 1304.
Device 1300 defines a light-fiber bundle lumen 1312 that extends along its length, from proximal end 1308 to distal tip 1310. Lumen 1312 contains a light-fiber bundle that, during use, directs light from a light source connected at proximal end 1308 and out through distal tip 1310 of device 1300. In some embodiments, lumen 1312 contains a single light-fiber (e.g., a 30 micron 0.44 NA illumination fiber or a 0.55-0.66 NA light fiber) while in other embodiment lumen 1312 contains multiple light-fibers. The light fiber may, for example, be able to conduct a light powerful enough to produce a 15,000 lux or greater illuminance at distal tip 1310.
In some embodiments, the light-fiber or fiber bundle may be adhered to the inside walls of lumen 1312 using an epoxy (e.g., EP42HT-CLEAR available from Master Bond, Inc. of Hackensack, N.J.). In other embodiments, the light-fiber or fiber bundle may be removably inserted or removably secured within lumen 1312 such that the light-fiber or fiber bundle can be removed from device 1300 at some point during use. For example, during use, a practitioner of the invention can insert the light fiber or fiber bundle into lumen 1312, use the lighted probe device to identify portions of the sinus cavity or sinus cavity drainage pathway or to confirm a location within the nasal or sinus system, remove the light-fiber or fiber bundle while leaving the body portion of device 1300 in place, and then use the lumen of device 1300 to guide other devices to a desired location. Alternatively, or in addition, the lumen of device 1300 could be attached to a vacuum source or a fluid could be directed through the lumen 1300 (thereby allowing a practitioner to apply suction or deliver water and/or a medicament to a desired location within a sinus system before, during, or after use of the light-fiber or fiber bundle). In a further example, the light-fiber or fiber bundle can be removed while leaving the remainder of device 1300 in a desired or confirmed location, thereby providing a visual guide along side of which a practitioner can guide other devices (e.g., a balloon dilation device) to the desired or confirmed location. In some embodiments, the invention includes a removable light-fiber or fiber bundle that includes an atraumatic tip (e.g., a spherical ball tip).
In some embodiments, device 1300 may be attached or connected to a light source at proximal end 1308 and the light source directs light into and through the fiber bundle in lumen 1312 and out distal tip 1310. Distal tip 1310 can include an atraumatic tip (as best illustrated in
The below Table 1 lists the numeric range of values that those dimensions can take depending upon the specific design parameters for a given embodiment of a lighted probe.
In some embodiments of the invention, the lighted probe is sized and dimensioned to match or access the frontal sinus outflow tract or frontal recess of a typical patient population, while in other embodiments the probe is sized and dimensioned to match or access the maxillary and/or sphenoid sinus outflow tracts and/or cavities. For example, a lighted probe having an Angle α of about zero degrees (essentially a straight probe) would be particularly useful for accessing the sphenoid sinus spaces. In some preferred embodiments, angle α is in a range of from about 28 degrees to about 88 degrees while the other dimensions angle α fall within the ranges listed in Table 1. In an especially preferred embodiment, length L1 is about 7.067 inches, length L2 is about 2.777 inches, length L3 is about 1.930 inches, length L4 is about 0.639 inches, length L5 is about 0.210 inches, an angle α is about 58 degrees, and a radius of curvature R of about 0.850 inches. In another especially preferred embodiment, length L1 is about 6.886 inches, length L2 is about 2.616 inches, length L3 is about 1.931 inches, length L4 is about 0.763 inches, length L5 is about 0.210 inches, an angle α is about 78 degrees, and a radius of curvature R of about 0.630 inches. In another especially preferred embodiment, particularly suited for use in the maxillary sinus cavities and outflow tract, angle α is between about 60 and about 120 degrees, the radius of curvature R is between 0.125 and 0.50 inches, and length L4 is between about 0.150 and 0.750 inches.
In some embodiments, the atraumatic ball tip of distal tip 1310 has a diameter in the range of between about 0.5 millimeters to about 2.5 millimeters, while in some specific embodiments the atraumatic ball tip has as diameter of about 0.060 inches.
In some embodiments, probe member 1304 has an inner wall diameter of between 0.0195 inches and 0.0225 inches and an outer wall diameter of between 0.1089 inches and 0.1092 inches. In some embodiments, the distal portion of probe member 1304 has an outer wall diameter that tapers gradually to a narrowed distal tip.
Prior or after use, the lighted probe can be sterilized via autoclaving, EtOH sterilization, or gamma irradiation.
In some embodiments, the invention includes the use of a light source having a distal portion that can be detached.
Frequently, whenever two light-conducting elements join at a juncture, heat is generated when light crosses the juncture due to imperfections in the juncture. This is especially true when the juncture is between light-conducting elements made of disparate materials (e.g., one made of glass fiber and a second made of a polymeric fiber). In some cases, the heat generated can be quite substantial and can damage the light-conducting elements or burn an operator. In some embodiments, this invention includes a connector used to connect a light source of the invention with a light cable. The connector provides a juncture between the light source and the light cable that can reduce the amount of heat generated, and/or dissipates generated heat, more effectively and safely than if the light source and light cable were joined without the connector.
In use, light is transmitted across junction 1806 from light cable 1802 to light taper 1814, where it is concentrated and focused into glass fiber 1812. The light then travels along glass fiber 1812, across junction 1806, and into proximal end 1804. While some amount of heat may be generated at junctions 1806 and 1808, the heat is easily dissipated by housing 1810, thereby preventing a undesirable amount of heat from building up in the assembly components.
Guide catheter 1902 includes hypotube 1906 having malleable distal end 1904 and rigid distal portion 1910. Hypotube 1906 extends through handle 1908, with malleable distal end 1906 and a distal portion of rigid distal portion 1910 extending from distal end 1912 of handle 1908. Hypotube 1906 defines a lumen extending from proximal portion 1914 to distal tip of malleable distal end 1912. Second proximal portion 1916 defines a second lumen that joins together and is in fluid communication with the lumen defined by hypotube 1906.
Removable light-fiber 1900 is illustrated in
In use, distal tip 1922 of light-fiber 1900 is directed into proximal portion 1914 of catheter 1902, through the lumen defined by hypotube 1906, and to the distal tip of malleable distal end 1904. A light source is connected to proximal light connector 1924 so that light is conducted along light-fiber 1920 and projected out from distal tip 1922. Light-fiber 1900 can be secured to catheter 1902 using connector 1930. In this way, the light conducting light-fiber 1900 is mounted within catheter 1902 such that the light from distal tip 1922 emanates from the distal end of catheter 1902. Once assembled to light-fiber 1900, catheter 1902 can be used to probe a sinus system and confirm, via transdermal illumination, when the position of the distal end of catheter 1902 is within a maxillary or frontal sinus structure. Catheter 1902 can also be used light a flashlight to illuminate sinus structures for viewing structures within the sinus system with an endoscope. Once viewing or transdermal confirmation has been completed, a user may withdraw both catheter 1902 and light-fiber 1900 from the sinus system or, alternatively, may remove light-fiber 1900 leaving catheter 1902 within the sinus system. Fluid (e.g., saline) or suction sources may be secured to second proximal portion 1916 in order to direct fluid from the distal end of malleable distal end 1904 or suction material into and through catheter 1902.
In some embodiments of the invention, a portable light source may be used and attached to the light-conducting devices described herein (e.g., device 1300 or light-fiber 1900). The portable light source may include a battery-powered LED light source.
In some embodiments of the invention, light of various wavelengths may be directed through the light-conducting devices described herein (e.g., device 1300 or light-fiber 1900). Red or infrared light tends to pass through blood and tissue more easily than light of other spectrums, so use of red light can be desirable when performing transdermal illumination. Hence, in some embodiments of the invention, a red light may be used with the light-conducting devices described herein when the devices are used to illuminate transdermally while a white light may be used when the devices are used to view structures with an endoscope. In some embodiments of the invention, a portable light source having two dissimilar colors of light (e.g., white and red) is used with the light-conducting devices described herein, with the user toggling the light source between the two colors as desired during use.
While embodiments of the present invention have been shown and described, various modifications may be made without departing from the scope of the present invention. The invention, therefore, should not be limited, except to the following claims, and their equivalents.
This Application is a continuation of U.S. application Ser. No. 17/134,482 filed Dec. 27, 2020, which is a continuation of U.S. application Ser. No. 17/072,879 filed on Oct. 16, 2020, which is a continuation of U.S. application Ser. No. 16/011,397 filed on Jun. 18, 2018, which is a continuation of U.S. application Ser. No. 14/918,468 filed on Oct. 20, 2015, which is a continuation of U.S. application Ser. No. 14/468,617 filed on Aug. 26, 2014, which is a continuation of U.S. application Ser. No. 13/277,885 filed on Oct. 20, 2011, which is a continuation-in-part of U.S. application Ser. No. 12/479,521 filed on Jun. 5, 2009 and claims priority to U.S. Provisional Patent Application No. 61/405,035 filed on Oct. 20, 2010. Priority is claimed pursuant to 35 U.S.C. §§ 119 and 120. The above-noted Patent Applications are incorporated by reference as if set forth fully herein.
Number | Name | Date | Kind |
---|---|---|---|
2525183 | Robison | Oct 1950 | A |
3800788 | White | Apr 1974 | A |
4737141 | Spits | Apr 1988 | A |
5021043 | Becker et al. | Jun 1991 | A |
5024658 | Kozlov et al. | Jun 1991 | A |
5026367 | Leckrone | Jun 1991 | A |
5047045 | Arney | Sep 1991 | A |
5169386 | Becker et al. | Dec 1992 | A |
5195989 | Euteneuer | Mar 1993 | A |
5271400 | Dumoulin et al. | Dec 1993 | A |
5300063 | Tano | Apr 1994 | A |
5324257 | Osborne | Jun 1994 | A |
5391199 | Ben-Haim | Feb 1995 | A |
5415634 | Glynn et al. | May 1995 | A |
5441497 | Narciso, Jr. | Aug 1995 | A |
5443489 | Ben-Haim | Aug 1995 | A |
5466222 | Ressemann et al. | Nov 1995 | A |
5470315 | Adams | Nov 1995 | A |
5505725 | Samson | Apr 1996 | A |
5569274 | Rapacki et al. | Oct 1996 | A |
5588950 | Sano et al. | Dec 1996 | A |
5632762 | Myler | May 1997 | A |
5645528 | Thome | Jul 1997 | A |
5653230 | Ciaglia | Aug 1997 | A |
5725514 | Grinblat | Mar 1998 | A |
5795325 | Valley et al. | Aug 1998 | A |
5871462 | Yoder | Feb 1999 | A |
5964767 | Tapia et al. | Oct 1999 | A |
6083188 | Becker | Jul 2000 | A |
6090132 | Fox | Jul 2000 | A |
6113567 | Becker | Sep 2000 | A |
6179611 | Everett | Jan 2001 | B1 |
6206870 | Kanner | Mar 2001 | B1 |
6238364 | Becker | May 2001 | B1 |
6491940 | Levin | Dec 2002 | B1 |
6543452 | Levigne | Apr 2003 | B1 |
D501677 | Becker | Feb 2005 | S |
6851424 | Scopton | Feb 2005 | B2 |
7500971 | Chang et al. | Mar 2009 | B2 |
7520876 | Ressemann et al. | Apr 2009 | B2 |
7678099 | Ressemann et al. | Mar 2010 | B2 |
7785315 | Muni et al. | Aug 2010 | B1 |
7842062 | Keith et al. | Nov 2010 | B2 |
7879061 | Keith et al. | Feb 2011 | B2 |
7918871 | Truitt et al. | Apr 2011 | B2 |
8114113 | Becker | Feb 2012 | B2 |
8146400 | Goldfarb et al. | Apr 2012 | B2 |
8241266 | Keith et al. | Aug 2012 | B2 |
8277478 | Drontle et al. | Oct 2012 | B2 |
8282667 | Drontle et al. | Oct 2012 | B2 |
8348969 | Keith et al. | Jan 2013 | B2 |
8568439 | Keith et al. | Oct 2013 | B2 |
8585728 | Keith et al. | Nov 2013 | B2 |
8585729 | Keith et al. | Nov 2013 | B2 |
8623043 | Keith et al. | Jan 2014 | B1 |
8657846 | Keith et al. | Feb 2014 | B2 |
8801670 | Drontle et al. | Aug 2014 | B2 |
8834513 | Hanson et al. | Sep 2014 | B2 |
8882795 | Drontle et al. | Nov 2014 | B2 |
8888686 | Drontle et al. | Nov 2014 | B2 |
8915938 | Keith et al. | Dec 2014 | B2 |
8986340 | Drontle et al. | Mar 2015 | B2 |
9005284 | Ressemann | Apr 2015 | B2 |
9101739 | Lesch, Jr. et al. | Aug 2015 | B2 |
9192748 | Ressemann et al. | Nov 2015 | B2 |
9278199 | Keith et al. | Mar 2016 | B2 |
9282986 | Hanson et al. | Mar 2016 | B2 |
9283360 | Lesch et al. | Mar 2016 | B2 |
9320876 | Ressemann et al. | Apr 2016 | B2 |
9333327 | Setliff, III et al. | May 2016 | B2 |
9339637 | Drontle et al. | May 2016 | B2 |
9370650 | Hanson et al. | Jun 2016 | B2 |
9433343 | Drontle et al. | Sep 2016 | B2 |
9440049 | Drontle et al. | Sep 2016 | B2 |
9486614 | Drontle et al. | Nov 2016 | B2 |
9550049 | Hanson et al. | Jan 2017 | B2 |
9694167 | Keith et al. | Jul 2017 | B2 |
9700705 | Lesch, Jr. et al. | Jul 2017 | B2 |
9775975 | Ressemann et al. | Oct 2017 | B2 |
10022525 | Hanson et al. | Jul 2018 | B2 |
10029069 | Keith et al. | Jul 2018 | B2 |
10086181 | Lesch et al. | Oct 2018 | B2 |
20020065455 | Ben-Haim | May 2002 | A1 |
20020138121 | Fox | Sep 2002 | A1 |
20030023143 | Abe et al. | Jan 2003 | A1 |
20030120208 | Houser | Jun 2003 | A1 |
20040064083 | Becker | Apr 2004 | A1 |
20040064150 | Becker | Apr 2004 | A1 |
20040068299 | Laske et al. | Apr 2004 | A1 |
20040162556 | Swanson | Aug 2004 | A1 |
20050015123 | Paithankar | Jan 2005 | A1 |
20050059931 | Garrison | Mar 2005 | A1 |
20050075661 | Levine et al. | Apr 2005 | A1 |
20050234436 | Baxter | Oct 2005 | A1 |
20050240147 | Makower | Oct 2005 | A1 |
20050241399 | Lopushansky | Nov 2005 | A1 |
20050245906 | Makower | Nov 2005 | A1 |
20050251119 | Eaton et al. | Nov 2005 | A1 |
20060004286 | Chang | Jan 2006 | A1 |
20060004323 | Chang | Jan 2006 | A1 |
20060063973 | Makower | Mar 2006 | A1 |
20060095066 | Chang | May 2006 | A1 |
20060100687 | Fahey | May 2006 | A1 |
20060106361 | Muni et al. | May 2006 | A1 |
20060111691 | Bolmsjo et al. | May 2006 | A1 |
20060149310 | Becker | Jul 2006 | A1 |
20060195014 | Seibel et al. | Aug 2006 | A1 |
20060210605 | Chang | Sep 2006 | A1 |
20060252993 | Freed et al. | Nov 2006 | A1 |
20060284428 | Beadle et al. | Dec 2006 | A1 |
20070005094 | Eaton | Jan 2007 | A1 |
20070073160 | Imam | Mar 2007 | A1 |
20070073269 | Becker | Mar 2007 | A1 |
20070129751 | Muni et al. | Jun 2007 | A1 |
20070135789 | Chang et al. | Jun 2007 | A1 |
20070135803 | Belson | Jun 2007 | A1 |
20070208252 | Makower | Jun 2007 | A1 |
20070167682 | Goldfarb et al. | Jul 2007 | A1 |
20070208301 | Evard et al. | Sep 2007 | A1 |
20070249896 | Goldfarb | Oct 2007 | A1 |
20070250105 | Ressemann | Oct 2007 | A1 |
20070270644 | Goldfarb et al. | Nov 2007 | A1 |
20070282305 | Goldfarb et al. | Dec 2007 | A1 |
20070293726 | Goldfarb et al. | Dec 2007 | A1 |
20070293727 | Goldfarb et al. | Dec 2007 | A1 |
20080015472 | Ressemann et al. | Jan 2008 | A1 |
20080015540 | Muni et al. | Jan 2008 | A1 |
20080033353 | Truitt et al. | Feb 2008 | A1 |
20080077173 | Flanagan | Mar 2008 | A1 |
20080082045 | Goldfarb et al. | Apr 2008 | A1 |
20080097154 | Makower et al. | Apr 2008 | A1 |
20080097239 | Chang et al. | Apr 2008 | A1 |
20080097295 | Makower et al. | Apr 2008 | A1 |
20080097400 | Chang et al. | Apr 2008 | A1 |
20080097514 | Chang et al. | Apr 2008 | A1 |
20080097515 | Chang et al. | Apr 2008 | A1 |
20080097516 | Chang et al. | Apr 2008 | A1 |
20080103521 | Makower et al. | May 2008 | A1 |
20080119693 | Makower et al. | May 2008 | A1 |
20080125626 | Chang | May 2008 | A1 |
20080132938 | Chang et al. | Jun 2008 | A1 |
20080154217 | Carrez et al. | Jun 2008 | A1 |
20080154237 | Chang et al. | Jun 2008 | A1 |
20080154250 | Makower et al. | Jun 2008 | A1 |
20080167527 | Slenker | Jul 2008 | A1 |
20080172033 | Keith et al. | Jul 2008 | A1 |
20080195041 | Goldfarb | Aug 2008 | A1 |
20080228085 | Jenkins et al. | Sep 2008 | A1 |
20080234720 | Chang et al. | Sep 2008 | A1 |
20080249420 | Crossman | Oct 2008 | A1 |
20080269596 | Revie et al. | Oct 2008 | A1 |
20080275483 | Makower et al. | Nov 2008 | A1 |
20080281156 | Makower et al. | Nov 2008 | A1 |
20080287908 | Muni et al. | Nov 2008 | A1 |
20080312712 | Penner | Dec 2008 | A1 |
20080319424 | Muni et al. | Dec 2008 | A1 |
20090005763 | Makower et al. | Jan 2009 | A1 |
20090028923 | Muni et al. | Jan 2009 | A1 |
20090030274 | Goldfarb et al. | Jan 2009 | A1 |
20090073718 | Chung | Mar 2009 | A1 |
20090076329 | Su | Mar 2009 | A1 |
20090093823 | Chang et al. | Apr 2009 | A1 |
20090125046 | Becker | May 2009 | A1 |
20090132033 | Maurer et al. | May 2009 | A1 |
20090187098 | Makower et al. | Jul 2009 | A1 |
20090198216 | Muni et al. | Aug 2009 | A1 |
20090204142 | Becker | Aug 2009 | A1 |
20090216196 | Drontle | Aug 2009 | A1 |
20090318875 | Friedman | Dec 2009 | A1 |
20100016811 | Smith | Jan 2010 | A1 |
20100030113 | Morriss et al. | Feb 2010 | A1 |
20100070050 | Mathis | Mar 2010 | A1 |
20100168511 | Muni et al. | Jul 2010 | A1 |
20100211007 | Lesch | Aug 2010 | A1 |
20100241155 | Chang et al. | Sep 2010 | A1 |
20100274222 | Setliff, III et al. | Oct 2010 | A1 |
20100312101 | Drontle | Dec 2010 | A1 |
20110071349 | Drontle et al. | Mar 2011 | A1 |
20110112512 | Muni | May 2011 | A1 |
20110224652 | Drontle et al. | Sep 2011 | A1 |
20120010646 | Keith et al. | Jan 2012 | A1 |
20120184983 | Chang et al. | Jul 2012 | A1 |
20120283625 | Keith et al. | Nov 2012 | A1 |
20130030458 | Drontle et al. | Jan 2013 | A1 |
20130030459 | Drontle et al. | Jan 2013 | A1 |
20130041463 | Ressemann | Feb 2013 | A1 |
20130072958 | Ressemann et al. | Mar 2013 | A1 |
20130123833 | Lesch et al. | May 2013 | A1 |
20140350520 | Drontle et al. | Nov 2014 | A1 |
20140357959 | Hanson | Dec 2014 | A1 |
20140364700 | Hanson et al. | Dec 2014 | A1 |
20140378776 | Hanson | Dec 2014 | A1 |
20150031950 | Drontle et al. | Jan 2015 | A1 |
20150045827 | Drontle et al. | Feb 2015 | A1 |
20150105818 | Keith et al. | Apr 2015 | A1 |
20160038726 | Hanson et al. | Feb 2016 | A1 |
20160151614 | Ressemann et al. | Jun 2016 | A1 |
20160166814 | Lesch et al. | Jun 2016 | A1 |
20160367286 | Drontle et al. | Dec 2016 | A1 |
20160375229 | Setliff, III et al. | Dec 2016 | A1 |
20170007282 | Drontle | Jan 2017 | A1 |
20170028112 | Drontle et al. | Feb 2017 | A1 |
20170050001 | Drontle et al. | Feb 2017 | A1 |
20170113027 | Drontle et al. | Apr 2017 | A1 |
20170368319 | Lesch, Jr. et al. | Dec 2017 | A1 |
20180008806 | Ressemann et al. | Jan 2018 | A1 |
20180304051 | Keith et al. | Oct 2018 | A1 |
20180304058 | Hanson et al. | Oct 2018 | A1 |
Number | Date | Country |
---|---|---|
0129634 | Jan 1985 | EP |
1598015 | Nov 2005 | EP |
2009-505691 | Feb 2009 | JP |
91117787 | Nov 1991 | WO |
9600033 | Jan 1996 | WO |
2003086209 | Oct 2003 | WO |
2005086945 | Sep 2005 | WO |
2007035204 | Mar 2007 | WO |
2009065085 | May 2009 | WO |
2010014799 | Feb 2010 | WO |
2017135980 | Aug 2017 | WO |
2017192394 | Nov 2017 | WO |
Entry |
---|
Petersen, Robert J., Canine Fossa Puncture, The Laryngoscope Office, Oct. 5, 1972, pp. 369-371. |
Elidan, J., MD., Irrigation of the Maxillary Sinus by Canine Fossa Puncture Experience with 202 Patients, Ann Olol Rhinol Laryngal, 92:1983, pp. 528-529. |
Yanagisawa, Eiji, et al., Trans-Canine-Fossa Maxillary Sinoscopy for Biopsy Via the Stammberger Technique, ENT Rhinoscopic Clinic, Aug. 2001 Rhino, pp. 1-3. |
Yanagisawa, Eiji, et al., Powered Endoscopic Inferior Meatal Antrostomy Under Canine Fossa Telescopic Guidance, ENT—Ear, Nose & Throat Journal, Sep. 2001, pp. 618-620. |
Sathananthar, Shanmugam, et al., Canine Fossa Puncture and Clearance of the Maxillary Sinus for the Severely Diseased Maxillary Sinus, The Laryngoscope 115: Jun. 2005, pp. 1026-1029. |
Robinson, Simon, et al., Patterns of Innervation of the Anterior Maxilla: A Cadaver Study with Relevance to Canine Fossa Puncture of the Maxillary Sinus, Laryngoscope 115: Oct. 2005, pp. 1785-1788. |
Bolger, William, E., et al., Catheter-Based Dilation of the Sinus Ostia: Initial Safety and Feasibility Analysis in a Cadaver Model, Maryland Sinus Clinic, Bethesda, Maryland, and California Sinus Institute, Palo Alto, California, OceanSide Publications, Inc., May-Jun. 2006, vol. 20, No. 3, pp. 290-294. |
Friedman, Michael, M.D. et al., Functional Endoscopic Dilatation of the Sinuses (FEDS): Patient Selection and Surgical Technique, Operative Technologies in Otolaryngology, vol. 17, No. 2, Jun. 2006, pp. 126-134. |
Jones, Nick, Commentary on “Safety and Feasibility of Balloon Catheter Dilation of Paranasal Sinus Ostia: A Preliminary Investigation”, Annals of Otology, Rhinology & Laryngology 115(4), pp. 300-301 (2006). |
Bolger, William E., Commentary Misconceptions Regarding Balloon Catheter Dilation of Paranasal Sinus Ostia, Annals of Otology, Rhinology & Laryngology 115(10): 791-792 (2006). |
Lanza, Donald, C., et al., Commentary Balloon Sinuplasty: Not Ready for Prime Time, Annals of Otology, Rhinology & Laryngology 115(10): 789-790 (2006). |
Brown, Christopher, L., et al., “Safety and Feasibility of Balloon Catheter Dilation of Paranasal Sinus Ostia: A Preliminary Investigation”, Annals of Otology, Rhinology & Laryngology 115(4):293-299 (2006). |
Gottman, D., et al., “Balloon Dilatation of Recurrent Ostia Occlusion of the Frontal Sinus”, ECR Mar. 3, 2001, 2:-3:30 PM, Vienna Austria (1 page). |
Entellus Medical, 510(k) Premarket Notification cover letter and Attachment B: Predicate Device Labeling, dated Aug. 15, 2007. |
R. Peterson, Sinus Puncture Therreapy: Canine Fossa Puncture Method “How I Do It” Head and Neck, The Larynsgoscope 91: Dec. 1981, pp. 2126-2128. |
T.G.A. Ijaduola, Use of a Foley Catheter for Short-Term Drainage of Frontal Sinus Surgery, Journ. of Laryngology and Otology, Apr. 1989, vol. 103, pp. 375-378. |
A. Gatot et al., Early Treatment of Oribital Floor Fractures with Catheter Balloon in Childre, Inl'l. J. of Ped. Otorhinolaryngology, 21 (1991) 97-101. |
D.I. Tarasov et al., Treatment of Chronic Ethmoiditis by IntraCellular Administration of Medicines to the Ethmoidal Labyrinth, Vestn Otorinolaringol. Nov.-Dec. 1978; (6):45-47 (Abstract in English). |
J.M. Robison, Pressure Treatment of Maxillary Sinusitis, J.A.M.A., May 31, 1952, pp. 436-440. |
J.M. Robison, Pressure Treatment of Purulent Maxillary Sinusitis, Texas State Journal of Medicine, May 1952, pp. 81-288. |
Entellus Medical, 510(k) Letter (Amendment 1) and Attachment D&E, dated Mar. 13, 2008. |
Gottman et al., Balloon Dilation of Recurrent Ostial Occlusion of the Frontal Sinus, Gottman et al.: Abstract (B-0453) Mar. 2001, 22 pages. |
PCT International Search Report for PCT/US2007/088834, Applicant: Entellus Medical, Inc., Forms PCT/ISA/220 and PCT/ISA/210, dated May 20, 2008 (4 pages). |
PCT Written Opinion for PCT/US2007/088834, Applicant: Entellus Medical, Inc., Forms PCT/ISA/237, dated May 20, 2008 (10 pages). |
PCT International Search Report for PCT/US2007/66187, Applicant: Entellus Medical, Inc., Forms PCT/ISA/220 and PCT/ISA/210, dated Apr. 17, 2008 (5 pages). |
PCT Written Opinion for PCT/US2007/66187, Applicant: Entellus Medical, Inc., Forms PCT/ISA/237, dated Apr. 17, 2008 (5 pages). |
Folweiler, David S., Nasal Specific Technique as Part of a Chropractic Approach to Chronic Sinusitis and Sinus Headaches, Journal of Manipulative and Physiological Therapeutics, vol. 18, No. 1 (Jan. 1995). |
PCT International Preliminary Report on Patentability (Chapter I of the Patent Cooperation Treaty) of the International Bureau for PCT/US2007/066187, Applicant: Entellus Medical, Inc., Form PCT/IB/326, dated Oct. 30, 2006 (4 pages). |
Medtronic, ENT Image-Guided Surgery System, http://www.xomed.com/xomed_products_element.html, Jun. 3, 2009 (2 pages). |
PCT International Preliminary Report on Patentability (Chapter I of the Patent Cooperation Treaty) for PCT/US2010/037508, Applicant: Entellus Medical Inc., Form PCT/IB/326 and 373, dated Dec. 15, 2011 (6 pages). |
Fiber-optic Surgical Probe, http://www.anthonyproducts.com/store/p-389-fiber-optic-surgical-probe.aspx, 1 page, at least as early as Jul. 12, 2011. |
Light Probe Kit, http://www.fiberoptix.com/products/light-probe-kit.html, 2 pages, Apr. 2010. |
International Search Report dated Aug. 2, 2010, for PCT/US2010/037508, Applicant: Entellus Medical, Inc. (4 pages). |
Written Opinion of the International Search Authority dated Aug. 2, 2010, for PCT/US2010/037508, Applicant: Entellus Medical, Inc. (4 pages). |
Iro, H., J. Zenk. “A new device for frontal sinus endoscopy: First Clinical Report”, Department of Otorhinolaryngology, University of Eralngen-Nuremberg, Germany. Otorhinolaryngology, Head and Neck Surgery vol. 125 No. 6, Dec. 2001, pp. 613-616 (4 pages). |
International Preliminary Report on Patentability dated Jul. 30, 2009, for PCT/US2007/088834, Applicant: Entellus Medical, Inc. (9 pages). |
File History of U.S. Appl. No. 14/460,912, filed Aug. 15, 2014, inventor: Anthony J. Hanson, including Office Action dated Feb. 10, 2015 (26pages). |
File History of U.S. Appl. No. 14/468,595, filed Aug. 26, 2014, inventor: Anthony J. Hanson, including Office Action dated Jan. 28, 2015 (26pages). |
Final Office Action dated Sep. 22, 2015 in U.S. Appl. No. 14/468,595, filed Aug. 26, 2014, (16pp). |
Final Office Action dated Oct. 5, 2015 in U.S. Appl. No. 14/460,912, filed Aug. 15, 2014, (15pp). |
Number | Date | Country | |
---|---|---|---|
20210154451 A1 | May 2021 | US |
Number | Date | Country | |
---|---|---|---|
61405035 | Oct 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17134482 | Dec 2020 | US |
Child | 17153579 | US | |
Parent | 17072879 | Oct 2020 | US |
Child | 17134482 | US | |
Parent | 16011397 | Jun 2018 | US |
Child | 17072879 | US | |
Parent | 14918468 | Oct 2015 | US |
Child | 16011397 | US | |
Parent | 14468617 | Aug 2014 | US |
Child | 14918468 | US | |
Parent | 13277885 | Oct 2011 | US |
Child | 14468617 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12479521 | Jun 2009 | US |
Child | 13277885 | US |